Article Versions Notes

Vallecillo-Zúniga ML, Poulson PD, Luddington JS, Arnold CJ, Rathgeber M, Kartchner BC, Hayes S, Gill H, Valdoz JC, Spallino JL, et al. Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B. Cells. 2021; 10(11):3210. https://doi.org/10.3390/cells10113210

Vallecillo-Zúniga, Mary L., Peter Daniel Poulson, Jacob S. Luddington, Christian J. Arnold, Matthew Rathgeber, Braden C. Kartchner, Spencer Hayes, Hailie Gill, Jonard C. Valdoz, Jonathan L. Spallino, and et al. 2021. "Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B" Cells 10, no. 11: 3210. https://doi.org/10.3390/cells10113210

Vallecillo-Zúniga, M. L., Poulson, P. D., Luddington, J. S., Arnold, C. J., Rathgeber, M., Kartchner, B. C., Hayes, S., Gill, H., Valdoz, J. C., Spallino, J. L., Garfield, S., Dodson, E. L., Arthur, C. M., Stowell, S. R., & Van Ry, P. M. (2021). Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B. Cells, 10(11), 3210. https://doi.org/10.3390/cells10113210